Notably, low SHNG12 expression levels were associated with favorable long-term survival rates in patients with LUAD (Figure 10(b)), and SNHG12 expression was significantly increased in patients with NSCLC (Figure 10(c)). This evidence concerns the gene SNHG12 and non-small cell lung carcinoma.